Sanofi reported EUR9.92B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
AbbVie USD 10.27B 1000K Jun/2026
Aena EUR 887.54M 119.08M Jun/2026
Alcon AG USD 2.41B 4M Mar/2026
Almirall EUR 531.16M 13.76M Jun/2026
Amarin USD 51.48M 113K Dec/2025
Amgen USD 4.78B 1.12B Mar/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
Bayer EUR 9.88B 452M Mar/2026
Biogen USD 2.98B 1.02B Jun/2026
BMW EUR 29B 2.33B Mar/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Eli Lilly USD 10.02B 285M Mar/2026
Essilor EUR 12.52B 568M Jun/2026
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Genmab DKK 798M 235M Dec/2025
Gilead Sciences USD 23.52B 18.55B Mar/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GRIFOLS EUR 1.55B 94M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
J&J USD 17.83B 388M Jun/2026
Lakefront Biotherapeutics EUR 70.18M 50.08M Mar/2026
Lonza CHF 2.9B 184M Jun/2025
Mercedes-Benz AG EUR 29.39B 308M Jun/2026
Merck EUR 4.09B 687M Mar/2026
Merck USD 18.17B 8.01B Mar/2026
Novartis USD 10.2B 912M Jun/2026
Novo Nordisk DKK 37.21B 9.56B Mar/2026
Orion EUR 345M 42.1M Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Philips EUR 3.75B 147M Jun/2026
Recordati EUR 493.59M 11.28M Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Sanofi EUR 8.98B 1.73B Mar/2026
SAP EUR 7.24B 11.46B Jun/2026
UCB EUR 2.96B 196M Dec/2025
Vinci EUR 32.03B 2.09B Jun/2026
Volkswagen EUR 78.98B 7.05B Jun/2026